| Bioactivity | β-Lactamase-IN-1 is an inhibitor of β-Lactamase extracted from patent WO2016027249A1, page 77. β-Lactamase-IN-1 can be used to prepare of tricyclic nitrogen containing compound. β-Lactamase-IN-1 can be used for the research of neisseria gonorrhea infection[1]. | ||||||||||||
| Invitro | β-Lactamase-IN-1 can be used to prepare of tricyclic nitrogen containing compound which is an antibacterial agent[1]. | ||||||||||||
| Name | β-Lactamase-IN-1 | ||||||||||||
| CAS | 1075237-97-6 | ||||||||||||
| Formula | C11H13N3O4 | ||||||||||||
| Molar Mass | 251.24 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Widdowson KL. Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection. WO2016027249A1. |
β-Lactamase-IN-1
CAS: 1075237-97-6 F: C11H13N3O4 W: 251.24
β-Lactamase-IN-1 is an inhibitor of β-Lactamase extracted from patent WO2016027249A1, page 77. β-Lactamase-IN-1 can b
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.